| The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin M Hoenigl, R Sprute, M Egger, A Arastehfar, OA Cornely, R Krause, ... Drugs 81, 1703-1729, 2021 | 218 | 2021 |
| Hope on the horizon: novel fungal treatments in development AM Rauseo, A Coler-Reilly, L Larson, A Spec Open forum infectious diseases 7 (2), ofaa016, 2020 | 167 | 2020 |
| Underreporting of blood and body fluid exposures among health care students and trainees in the acute care setting: a 2007 survey CS Kessler, M McGuinn, A Spec, J Christensen, R Baragi, RC Hershow American journal of infection control 39 (2), 129-134, 2011 | 153 | 2011 |
| T cells from patients with Candida sepsis display a suppressive immunophenotype A Spec, Y Shindo, CAD Burnham, S Wilson, EA Ablordeppey, ER Beiter, ... Critical care 20, 1-9, 2016 | 125 | 2016 |
| Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International … GR Thompson, T Le, A Chindamporn, CA Kauffman, ... The Lancet Infectious Diseases 21 (12), e364-e374, 2021 | 118 | 2021 |
| Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM SCA Chen, J Perfect, AL Colombo, OA Cornely, AH Groll, D Seidel, ... The Lancet Infectious Diseases 21 (12), e375-e386, 2021 | 110 | 2021 |
| Community-Associated Methicillin-Resistant Staphylococcus aureus Colonization Burden in HIV-Infected Patients KJ Popovich, B Hota, A Aroutcheva, L Kurien, J Patel, R Lyles-Banks, ... Clinical infectious diseases 56 (8), 1067-1074, 2013 | 108 | 2013 |
| Coronavirus disease 2019–associated invasive fungal infection JW Baddley, GR Thompson III, SCA Chen, PL White, MD Johnson, ... Open forum infectious diseases 8 (12), ofab510, 2021 | 98 | 2021 |
| Comparative epidemiology and outcomes of human immunodeficiency virus (HIV), non-HIV non-transplant, and solid organ transplant associated cryptococcosis: a population-based study IA George, A Spec, WG Powderly, CAQ Santos Clinical infectious diseases 66 (4), 608-611, 2018 | 98* | 2018 |
| Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study C Mejia-Chew, JA O'Halloran, MA Olsen, D Stwalley, R Kronen, C Lin, ... The Lancet Infectious Diseases 19 (12), 1336-1344, 2019 | 93 | 2019 |
| A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus–negative people in the United States KA Marr, Y Sun, A Spec, N Lu, A Panackal, J Bennett, P Pappas, ... Clinical Infectious Diseases 70 (2), 252-261, 2020 | 81 | 2020 |
| MSG-10: a phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis A Spec, J Pullman, GR Thompson III, WG Powderly, EH Tobin, J Vazquez, ... Journal of Antimicrobial Chemotherapy 74 (10), 3056-3062, 2019 | 81* | 2019 |
| Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial GR Thompson, A Soriano, OA Cornely, BJ Kullberg, M Kollef, J Vazquez, ... The Lancet 401 (10370), 49-59, 2023 | 65 | 2023 |
| End-stage liver disease is a strong predictor of early mortality in cryptococcosis A Spec, K Raval, WG Powderly Open Forum Infectious Diseases 3 (1), ofv197, 2016 | 58 | 2016 |
| Invasive fungal infections secondary to traumatic injury R Kronen, SY Liang, G Bochicchio, K Bochicchio, WG Powderly, A Spec International Journal of Infectious Diseases 62, 102-111, 2017 | 57 | 2017 |
| Cryptococcosis today: it is not all about HIV infection JA O’Halloran, WG Powderly, A Spec Current Clinical Microbiology Reports 4, 88-95, 2017 | 56 | 2017 |
| Impact of infectious diseases consultation on mortality of cryptococcal infection in patients without HIV A Spec, MA Olsen, K Raval, WG Powderly Clinical Infectious Diseases 64 (5), 558-564, 2017 | 56 | 2017 |
| Disseminated cryptococcosis with brain involvement in patients with chronic lymphoid malignancies on ibrutinib JA Messina, EK Maziarz, A Spec, DP Kontoyiannis, JR Perfect Open forum infectious diseases 4 (1), ofw261, 2017 | 56 | 2017 |
| Abatacept, cenicriviroc, or infliximab for treatment of adults hospitalized with COVID-19 pneumonia: a randomized clinical trial JA O’Halloran, ER Ko, KJ Anstrom, E Kedar, MW McCarthy, RA Panettieri, ... JAMA 330 (4), 328-339, 2023 | 44* | 2023 |
| Presentation and mortality of cryptococcal infection varies by predisposing illness: a retrospective cohort study MA Hevey, IA George, K Raval, WG Powderly, A Spec The American journal of medicine 132 (8), 977-983. e1, 2019 | 42 | 2019 |
Adriana M RauseoWashington UniversityVerified email at wustl.edu
